Magnus Halle - GH Research CoFounder Ireland

GHRS Stock  USD 10.13  0.52  4.88%   

Insider

Magnus Halle is CoFounder Ireland of GH Research PLC
Age 28
Address Joshua Dawson House, Dublin, Ireland, D02 RY95
Phone353 1 437 8334
Webhttps://www.ghres.com

GH Research Management Efficiency

The company has return on total asset (ROA) of (0.1515) % which means that it has lost $0.1515 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1958) %, meaning that it created substantial loss on money invested by shareholders. GH Research's management efficiency ratios could be used to measure how well GH Research manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.15 in 2025. Return On Capital Employed is likely to drop to -0.18 in 2025. Non Current Assets Total is likely to gain to about 75.1 M in 2025, whereas Total Assets are likely to drop slightly above 168.7 M in 2025.
GH Research PLC currently holds 974 K in liabilities. GH Research PLC has a current ratio of 84.3, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about GH Research's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

JD MBAMonte Rosa Therapeutics
46
Dr MBAMediciNova
60
Seth LewisMolecular Partners AG
N/A
Silvia BuonamiciMonte Rosa Therapeutics
N/A
Randi MDWerewolf Therapeutics
69
Christopher GarciaArcus Biosciences
N/A
Mirella ToroAnnexon
N/A
Maryann CiminoPharvaris BV
N/A
Thomas SchwerzmannMolecular Partners AG
N/A
Joo MDDesign Therapeutics
61
FACC MDStoke Therapeutics
61
Esq JDAnnexon
56
Merdad ParseyArcus Biosciences
58
MD MPHMediciNova
56
Arnon RosenthalAnnexon
68
MBA MDIkena Oncology
59
Niels SvenstrupPepGen
55
MA MBARelay Therapeutics
48
Ted YednockAnnexon
67
Byron JDJanux Therapeutics
60
CPA CPAStoke Therapeutics
63
GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. GH Research PLC was incorporated in 2018 and is based in Dublin, Ireland. Gh Research is traded on NASDAQ Exchange in the United States. GH Research PLC (GHRS) is traded on NASDAQ Exchange in USA. It is located in Joshua Dawson House, Dublin, Ireland, D02 RY95 and employs 8 people. GH Research is listed under Biotechnology category by Fama And French industry classification.

Management Performance

GH Research PLC Leadership Team

Elected by the shareholders, the GH Research's board of directors comprises two types of representatives: GH Research inside directors who are chosen from within the company, and outside directors, selected externally and held independent of GHRS. The board's role is to monitor GH Research's management team and ensure that shareholders' interests are well served. GH Research's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, GH Research's outside directors are responsible for providing unbiased perspectives on the board's policies.
Julie ACA, VP Fin
Magnus Halle, CoFounder Ireland
Naoise Gaffney, VP Property
Velichka MD, Chief Officer
Florian M, CoFounder Chairman
Theis MD, CoFounder CEO
Aaron MBA, Chief Officer
Julie FCA, Vice Finance

GHRS Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is GH Research a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for GHRS Stock Analysis

When running GH Research's price analysis, check to measure GH Research's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GH Research is operating at the current time. Most of GH Research's value examination focuses on studying past and present price action to predict the probability of GH Research's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GH Research's price. Additionally, you may evaluate how the addition of GH Research to your portfolios can decrease your overall portfolio volatility.